FDA Inspection 979392 — Jazz Pharmaceuticals, Inc

Jazz Pharmaceuticals, Inc — FEI 3005615655

The FDA completed an inspection of Jazz Pharmaceuticals, Inc on January 27, 2016 in Palo Alto, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Palo Alto, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol